# A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

> **NCT07400029** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Obecabtagene Autoleucel

## Key facts

- **NCT ID:** NCT07400029
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-03
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07400029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07400029, "A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07400029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*